Trial intelligence / Profile preview

Danlu Capsule Post-Marketing Safety and Effectiveness Study in Hyperplasia of Mammary Glands

CTR20180325Phase 4Completed

Sponsor
Suzhong Pharmaceutical Group Co., Ltd.
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Danlu Capsule in breast hyperplasia, sponsored by Suzhong Pharmaceutical Group Co., Ltd.. Started Mar 2018; status: completed.

02

Drugs

Danlu Capsule
03

Conditions

breast hyperplasia

Beyond the preview

Go deeper on CTR20180325.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20180325.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call